CN106912949A - 一种灰树花螺旋藻复方保健食品及其制备方法 - Google Patents
一种灰树花螺旋藻复方保健食品及其制备方法 Download PDFInfo
- Publication number
- CN106912949A CN106912949A CN201710152547.7A CN201710152547A CN106912949A CN 106912949 A CN106912949 A CN 106912949A CN 201710152547 A CN201710152547 A CN 201710152547A CN 106912949 A CN106912949 A CN 106912949A
- Authority
- CN
- China
- Prior art keywords
- parts
- spirulina
- preparation
- powder
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000002900 Arthrospira platensis Species 0.000 title claims abstract description 31
- 235000016425 Arthrospira platensis Nutrition 0.000 title claims abstract description 31
- 229940082787 spirulina Drugs 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 241000222684 Grifola Species 0.000 title claims abstract description 23
- 235000013402 health food Nutrition 0.000 title claims abstract description 11
- 210000004369 blood Anatomy 0.000 claims abstract description 30
- 239000008280 blood Substances 0.000 claims abstract description 30
- 239000000843 powder Substances 0.000 claims abstract description 25
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 20
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 20
- 150000001875 compounds Chemical class 0.000 claims abstract description 17
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 16
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 15
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 15
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 15
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 15
- 230000036772 blood pressure Effects 0.000 claims abstract description 12
- 235000013305 food Nutrition 0.000 claims abstract description 12
- 229940046536 tree pollen allergenic extract Drugs 0.000 claims abstract description 11
- 239000002131 composite material Substances 0.000 claims abstract description 9
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 238000003801 milling Methods 0.000 claims abstract description 3
- 238000003809 water extraction Methods 0.000 claims abstract description 3
- 230000000694 effects Effects 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 6
- 230000033228 biological regulation Effects 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 3
- 230000035764 nutrition Effects 0.000 claims description 3
- 235000016709 nutrition Nutrition 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 240000001080 Grifola frondosa Species 0.000 claims description 2
- 235000007710 Grifola frondosa Nutrition 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- -1 electuary Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 235000013376 functional food Nutrition 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 claims 1
- 235000009200 high fat diet Nutrition 0.000 abstract description 8
- 108010028554 LDL Cholesterol Proteins 0.000 abstract description 4
- 210000002966 serum Anatomy 0.000 abstract description 4
- 238000002474 experimental method Methods 0.000 abstract description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract description 3
- 230000006698 induction Effects 0.000 abstract description 2
- 230000037356 lipid metabolism Effects 0.000 abstract 1
- 230000003285 pharmacodynamic effect Effects 0.000 abstract 1
- 230000036541 health Effects 0.000 description 16
- 239000000243 solution Substances 0.000 description 10
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 208000008589 Obesity Diseases 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 235000020824 obesity Nutrition 0.000 description 5
- 240000008397 Ganoderma lucidum Species 0.000 description 4
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 230000003345 hyperglycaemic effect Effects 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 235000007466 Corylus avellana Nutrition 0.000 description 2
- 240000003211 Corylus maxima Species 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 208000017170 Lipid metabolism disease Diseases 0.000 description 2
- 240000005819 Magnolia denudata Species 0.000 description 2
- 235000016094 Magnolia denudata Nutrition 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000208343 Panax Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003288 anthiarrhythmic effect Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 230000009194 climbing Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 229940089161 ginsenoside Drugs 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- DEDOPGXGGQYYMW-UHFFFAOYSA-N molinate Chemical compound CCSC(=O)N1CCCCCC1 DEDOPGXGGQYYMW-UHFFFAOYSA-N 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种灰树花螺旋藻复方保健食品及其制备方法,主要原料按重量份数计包括:灰树花粉1‑10份,螺旋藻粉1‑5份,山药1‑10份,西洋参1‑3份,绞股蓝2‑5份,将这些原料采用磨粉、热水浸提、过滤、减压浓缩干燥得到复合物干粉,以复合物干粉为原料制备具有调节血糖血脂的复合保健食品。经药效学实验验证,此复方保健食品能够显著的改善高脂饮食诱导的脂质代谢紊乱,特别地,能够显著的降低血清中总胆固醇(TC)、甘油三脂(TG)以及低密度脂蛋白胆固醇(LDL‑C)及血糖(GT)的水平。
Description
技术领域
本发明属于保健食品技术领域,具体涉及一种灰树花螺旋藻复方保健食品及其制备方法。
背景技术
随着生活水平的提高和生活节奏的改变,被称为“富贵病”的“三高症”发病率越来越高,特别是50岁以上中老年人健康的常见病,高血脂可以引起血管栓塞;高血压可以引起脑出血和脑血管破裂;高血糖可以引起糖尿病。全世界每年死于心脑血管疾病的人数高达1500万人,居各种死因首位。因此寻找开发具有降血脂血压的保健品,以辅助药物治疗,在有效的控制血糖和血脂的同时降低副作用已引起人们的关注。
灰树花:灰树花呈灰色或淡褐色,肉质嫩脆、味如鸡丝,脆似玉兰、鲜美诱口。灰树花营养十分丰富,营养价值很高,所含氨基酸、蛋白质比香菇高出一倍,具有防癌、抗癌及提高人体免疫功能的作用,对肝硬化、糖尿病、水肿、脚气病、小便不利等症有显著疗效。常食能补身健体,益寿延年。螺旋藻:原核生物,由单细胞或多细胞组成的丝状体,圆柱形,呈疏松或紧密的有规则的螺旋旋形弯曲,形如钟表发条,故而得名。具有减轻癌症放疗、化疗的毒副反应,提高免疫功能,降低血脂等功效。山药具有滋养强壮,助消化,敛虚汗,止泻之功效。其最适宜与灵芝搭配服用,具有防治糖尿病的作用。西洋参是五加科人参属多年生草木植物,别名花旗参、洋参等,其主要成分为人参皂苷,可以有效增强中枢神经,达到静心凝神、消除疲劳、增强记忆力等作用。常服西洋参可以抗心律失常、抗心肌缺血、抗心肌氧化、强化心肌收缩能力,养胃生津,降血糖血脂等诸多功效。枸杞子富含枸杞多糖,绞股蓝又称天堂草,是葫芦科、绞股蓝属草质攀援植物。用绞股蓝与灵芝搭配煮水或泡茶喝,可治疗高血压、高血脂、高血糖,脂肪肝等症。且有保肝解毒、降血压、降血脂血糖的功效。
本发明以灰树花,螺旋藻,山药等为原料制备了一种复合型降血脂血压的保健品,该产品在血脂血压方面的效果显著由于市面上的保健单品,拥有较好的保健价值,在市场上具有广阔的开发前景。
发明内容
本发明的目的主提供一种配比简单,组方搭配合理,具有显著调节糖脂代谢紊乱、增强机体的免疫力等功效的的复合保健食品。
为了实现上述目的,本发明采用如下技术方案:
一种调节血糖血脂的灰树花螺旋藻复合保健食品及其制备方法,根据中医的“君臣佐使”理论和现代营养学知识,将原料按所述配比经磨粉、热水浸提、过滤、减压浓缩干燥得到复合物干粉,以复合物干粉为原料制备具有调节血糖、血脂、血压及保肝等功效的营养功能性食品。其主要原料配方按重量份数计包括:灰树花粉1-10份,螺旋藻粉1-5份,山药1-10份,西洋参1-3份,绞股蓝2-5份。
所述的一种调节血糖血脂的灰树花螺旋藻复方保健食品及其制备方法,具体制备方法如下:
A.将灰树花子实体磨成细粉待用,按原料配比取灰树花粉,螺旋藻粉,山药,西洋参,绞股蓝,混合;
B.在步骤A的混合原料中加入20-50倍重量的水,于80-100℃提取罐中提取1-3h,经过滤得提取液和滤渣,将滤渣重复提取1-3次,合并提取液;
C. 将合并后的提取液置于过滤器中过滤,再于60-100℃、0.05-0.095MPa条件下浓缩,得浓缩液,经干燥得复合物粉末;
D. 将复合物粉末制备口服液,胶囊,片剂,冲剂,固体饮料,不同剂型的营养、功能性食品。
对本发明的组方原理作详细说明 :
灰树花:灰树花呈灰色或淡褐色,肉质嫩脆、味如鸡丝,脆似玉兰、鲜美诱口。灰树花营养十分丰富,营养价值很高,所含氨基酸、蛋白质比香菇高出一倍,具有防癌、抗癌及提高人体免疫功能的作用,对肝硬化、糖尿病、水肿、脚气病、小便不利等症有显著疗效。常食能补身健体,益寿延年。
螺旋藻:原核生物,由单细胞或多细胞组成的丝状体,圆柱形,呈疏松或紧密的有规则的螺旋旋形弯曲,形如钟表发条,故而得名。具有减轻癌症放疗、化疗的毒副反应,提高免疫功能,降低血脂等功效。
山药:山药具有滋养强壮,助消化,敛虚汗,止泻之功效。其最适宜与灵芝搭配服用,具有防治糖尿病的作用。
西洋参:西洋参是五加科人参属多年生草木植物,别名花旗参、洋参等,其主要成分为人参皂苷,可以有效增强中枢神经,达到静心凝神、消除疲劳、增强记忆力等作用。常服西洋参可以抗心律失常、抗心肌缺血、抗心肌氧化、强化心肌收缩能力,养胃生津,降血糖血脂等诸多功效。
绞股蓝:绞股蓝又称天堂草,是葫芦科、绞股蓝属草质攀援植物。用绞股蓝与灵芝搭配煮水或泡茶喝,可治疗高血压、高血脂、高血糖,脂肪肝等症。且有保肝解毒、辅助降血脂血糖的功效。
本发明的有益之处:
1.本发明全部采用天然物质为原料,不但可以直接辅助降血糖,而且能从一定程度上辅助降血脂。
2.本发明配伍科学,安全可靠,适于工业化生产。
3.本发明为一种灰树花螺旋藻复方保健品,该产品在调节血糖血脂方面的效果显著由于市面上的保健单品,拥有较好的保健价值,在市场上具有广阔的开发前景。
附图说明
图1为灰树花螺旋藻复方保健品对高脂饮食诱导肥胖大鼠的甘油三酯的影响作用;
图2为灰树花螺旋藻复方保健品对高脂饮食诱导肥胖大鼠的血清总胆固醇的影响作用;
图3为灰树花螺旋藻复方保健品对高脂饮食诱导肥胖大鼠的高密度脂蛋白的影响作用;
图4为灰树花螺旋藻复方保健品对高脂饮食诱导肥胖大鼠的低密度脂蛋白的影响作用。
具体实施方式
为了使本发明所述的内容更加便于理解,下面结合具体实施方式对本发明所述的技术方案做进一步的说明,但是本发明不仅限于此。
实施案例一:
一种灰树花螺旋藻复方保健食品的制备方法的步骤为:
A.按灰树花粉5份,螺旋藻粉2份,山药5份,西洋参1份,绞股蓝2份的原料配比(按重量份计),取灰树花粉,螺旋藻粉,山药,西洋参,绞股蓝,混合;
B.在步骤A的混合原料中加入30倍重量的水,于100℃提取罐中提取1h,经过滤得提取液和滤渣,将滤渣重复提取2次,合并提取液;
C. 将合并后的提取液置于过滤器中过滤,再于90℃、0.05-0.095MPa条件下浓缩,得浓缩液,经干燥得复合物粉末;
D. 将复合物粉末制备成调节血糖血脂的保健胶囊。
实施案例二:
一种灰树花螺旋藻复方保健食品的制备方法的步骤为:
A.按灰树花粉10份,螺旋藻粉5份,山药10份,西洋参3份,绞股蓝5份的原料配比(按重量份计),取灰树花粉,螺旋藻粉,山药,西洋参,绞股蓝,混合;
B.在步骤A的混合原料中加入40倍重量的水,于90℃提取罐中提取2h,经过滤得提取液和滤渣;
C. 将提取液置于过滤器中过滤,再于85℃、0.05-0.095MPa条件下浓缩10倍,得浓缩液;
D. 浓缩液按重量比加入阿斯巴甜500 ppm和苹果酸0.5%,制成辅助降血糖血脂的复合保健口服液。
E、调配好的口服液趁热用盐水瓶灌装、锁盖,经水浴杀菌并检验合格后即成为产品。
实施案例三:
一种灰树花螺旋藻复方保健食品的制备方法的步骤为:
A.按灰树花粉8份,螺旋藻粉3份,山药8份,西洋参2份,绞股蓝3份的原料配比(按重量份计),取灰树花粉,螺旋藻粉,山药,西洋参,绞股蓝,混合;
B.在步骤A的混合原料中加入20倍重量的水,于95℃提取罐中提取1h,经过滤得提取液和滤渣,将滤渣重复提取3次,合并提取液;
C. 将合并后的提取液置于过滤器中过滤,再于95℃、0.05-0.095MPa条件下浓缩10倍,得浓缩液;
D. 浓缩液按重量比加入阿斯巴甜300 ppm和苹果酸0.3%,制成辅助降血糖血脂的复合保健口服液。
E、调配好的口服液趁热用盐水瓶灌装、锁盖,经水浴杀菌并检验合格后即成为产品。
动物实验
实验方法:
以符合现代人类生活方式(动物性食物为主的高脂饮食***。实验结果如图1-4所示,从实验结果可知,就血清总胆固醇而言,模型组与正常组相比,结果有极显著性升高(P<0.01),复方组与模型组相比,结果有极显著性的降低(P<0.01),就甘油三酯而言,模型组与正常组比较,结果有极显著性的升高(P<0.01),复方组与模型组比较,有极显著性降低(P<0.01)。就高密度脂蛋白而言,模型组与正常组比较,结果有显著性降低(P<0.05),复方组与模型组比较,有显著性升高(P<0.05),就低密度脂蛋白而言,模型组与正常组比较,结果有极显著性升高(P<0.01),复方组与模型组比较,有极显著性降低(P<0.01)。
附录:该复方保健品对高脂饮食诱导肥胖大鼠血液指标的影响
注:“NFD”指的是空白组,灌胃生理盐水,喂正常饲料;
“HDF”指的是模型组,灌胃生理盐水;喂高脂饲料;
“GFSP”指用复方灌胃的实验组,喂高脂饲料;
以上所述仅为本发明的较佳实施例,凡依本发明申请专利范围所做的均等变化与修饰,皆应属本发明的涵盖范围。
Claims (3)
1.一种灰树花螺旋藻复方保健食品,其特征在于:所述复方保健食品的主要原料按重量份数计包括:灰树花粉1-10份,螺旋藻粉1-5份,山药1-10份,西洋参1-3份,绞股蓝2-5份。
2.一种如权利要求书1所述的灰树花螺旋藻复方保健食品的制备方法,其特征在于:将原料按配比经磨粉、热水浸提、过滤、减压浓缩干燥得到复合物干粉,以复合物干粉为原料制备具有调节血糖血脂功效的营养功能性食品。
3.根据权利要求书2所述的一种灰树花螺旋藻复方保健食品的制备方法,其特征在于:具体制备方法如下:
A.将灰树花子实体磨成细粉待用,按原料配比取灰树花粉,螺旋藻粉,山药,西洋参,绞股蓝,混合;
B.在步骤A的混合原料中加入20-50倍重量的水,于80-100℃提取罐中提取1-3h,经过滤得提取液和滤渣,将滤渣重复提取1-3次,合并提取液;
C. 将合并后的提取液置于过滤器中过滤,再于60-100℃、0.05-0.095MPa条件下浓缩,得浓缩液,经干燥得复合物粉末;
D. 将复合物粉末制备口服液,胶囊,片剂,冲剂,固体饮料,不同剂型的营养、功能性食品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710152547.7A CN106912949A (zh) | 2017-03-15 | 2017-03-15 | 一种灰树花螺旋藻复方保健食品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710152547.7A CN106912949A (zh) | 2017-03-15 | 2017-03-15 | 一种灰树花螺旋藻复方保健食品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106912949A true CN106912949A (zh) | 2017-07-04 |
Family
ID=59461881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710152547.7A Pending CN106912949A (zh) | 2017-03-15 | 2017-03-15 | 一种灰树花螺旋藻复方保健食品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106912949A (zh) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1102069A (zh) * | 1993-10-26 | 1995-05-03 | 江西信丰格林保健品公司 | 一种保健品兰宝素及其制备方法 |
CN1212889A (zh) * | 1997-09-29 | 1999-04-07 | 全龙浩 | 一种可提高免疫能力对多种疫病有效的中药组分 |
CN1293007A (zh) * | 1999-10-15 | 2001-05-02 | 吴建新 | 天然保健营养食品 |
CN101313756A (zh) * | 2008-07-18 | 2008-12-03 | 周纯喜 | 一种保健食品的制备方法 |
CN101715984A (zh) * | 2008-12-02 | 2010-06-02 | 天津天狮生物发展有限公司 | 一种螺旋藻胶囊及其生产制作工艺 |
CN102356837A (zh) * | 2011-09-23 | 2012-02-22 | 合肥工业大学 | 一种降血糖组合食物 |
CN102763839A (zh) * | 2012-05-29 | 2012-11-07 | 林树芳 | 一种清调补五行真菌口服制剂的制备方法 |
CN102987204A (zh) * | 2012-12-17 | 2013-03-27 | 江苏大学 | 灰树花营养粉及其制备方法 |
CN103877325A (zh) * | 2014-03-24 | 2014-06-25 | 陕西洋县志建药业科技有限公司 | 一种治疗心脑血管病的中药组合物及其制备方法 |
CN104435672A (zh) * | 2014-11-13 | 2015-03-25 | 成都华熹科技有限公司 | 一种含有松花粉的提高免疫力的中药组合物 |
CN106360679A (zh) * | 2016-08-27 | 2017-02-01 | 桂林七星粉业有限责任公司 | 一种具有降低血脂作用的螺旋藻保健胶囊的加工工艺 |
-
2017
- 2017-03-15 CN CN201710152547.7A patent/CN106912949A/zh active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1102069A (zh) * | 1993-10-26 | 1995-05-03 | 江西信丰格林保健品公司 | 一种保健品兰宝素及其制备方法 |
CN1212889A (zh) * | 1997-09-29 | 1999-04-07 | 全龙浩 | 一种可提高免疫能力对多种疫病有效的中药组分 |
CN1293007A (zh) * | 1999-10-15 | 2001-05-02 | 吴建新 | 天然保健营养食品 |
CN101313756A (zh) * | 2008-07-18 | 2008-12-03 | 周纯喜 | 一种保健食品的制备方法 |
CN101715984A (zh) * | 2008-12-02 | 2010-06-02 | 天津天狮生物发展有限公司 | 一种螺旋藻胶囊及其生产制作工艺 |
CN102356837A (zh) * | 2011-09-23 | 2012-02-22 | 合肥工业大学 | 一种降血糖组合食物 |
CN102763839A (zh) * | 2012-05-29 | 2012-11-07 | 林树芳 | 一种清调补五行真菌口服制剂的制备方法 |
CN102987204A (zh) * | 2012-12-17 | 2013-03-27 | 江苏大学 | 灰树花营养粉及其制备方法 |
CN103877325A (zh) * | 2014-03-24 | 2014-06-25 | 陕西洋县志建药业科技有限公司 | 一种治疗心脑血管病的中药组合物及其制备方法 |
CN104435672A (zh) * | 2014-11-13 | 2015-03-25 | 成都华熹科技有限公司 | 一种含有松花粉的提高免疫力的中药组合物 |
CN106360679A (zh) * | 2016-08-27 | 2017-02-01 | 桂林七星粉业有限责任公司 | 一种具有降低血脂作用的螺旋藻保健胶囊的加工工艺 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100559972C (zh) | 一种普洱茶保健饮料及其制备方法 | |
WO2016173509A1 (en) | Compositions comprising cyclocarya paliurus extract and preparation method and uses thereof | |
CN102048224B (zh) | 一种祛黄褐斑美容养颜红枣保健饮料及其生产工艺 | |
CN104621287B (zh) | 一种苦瓜肽茶组合物及其制备方法 | |
CN102726565A (zh) | 荞菊养生茶及其制备方法 | |
CN102293273A (zh) | 可调节血压、血糖、血脂并预防血栓、中风的养生茶 | |
CN102422957B (zh) | 八味丹参茶及其制备工艺 | |
CN102356789A (zh) | 一种降压保健茶 | |
CN105104638A (zh) | 一种白子菜复合茶及其制备方法 | |
CN107183259A (zh) | 一种普洱养生茶及其制备方法 | |
CN106942712A (zh) | 一种辅助降血脂的灵芝小球藻复方保健食品及其制备方法 | |
CN1736230B (zh) | 降脂减肥茶的制备方法 | |
CN101244208B (zh) | 一种治疗抑郁症及焦虑症的中药制剂的制备方法 | |
CN1060028C (zh) | 一种主要由谷物瓜菜果组成的健康食品 | |
CN105533749B (zh) | 一种含淫羊藿、五味子的保健食品及其制备方法和用途 | |
CN106912949A (zh) | 一种灰树花螺旋藻复方保健食品及其制备方法 | |
CN105853610A (zh) | 一种增强免疫力及延缓衰老的功能性保健品及其制备方法 | |
CN103316207A (zh) | 抗记忆力衰老天然药物复方 | |
CN1183936C (zh) | 一种治疗高血压病的药物及其茶剂制备方法 | |
CN105250729A (zh) | 一种铁斛冲剂及其制备方法 | |
CN109965278A (zh) | 一种养生营养粉 | |
CN107998353A (zh) | 一种健脾、益气的中药制剂及其制备方法 | |
CN107048259A (zh) | 用十三种珍贵食材配制的健康食品及其配制方法 | |
CN102613547A (zh) | 一种保护心脏的食疗产品及其制备方法 | |
CN101721453B (zh) | 一种延缓男性衰老的组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |